Form 4: PACCAR EVP Dozier Boosts Stake via Dividend Reinvestment
Insider Transaction Report
PACCAR Executive Vice President C. Michael Dozier increased his indirect beneficial ownership of common stock through a dividend reinvestment plan.
Summary
- C. Michael Dozier, Executive Vice President of PACCAR INC, reported a change in beneficial ownership of common stock.
- On December 3, 2025, Mr. Dozier acquired 61.354 shares of PACCAR Common Stock at a price of $108.54 per share.
- This acquisition was a dividend reinvestment (Transaction Code 'J') through the PACCAR Savings Investment Plan (SIP).
- Following this transaction, Mr. Dozier indirectly beneficially owns 19,921.03 shares of Common Stock through the SIP.
- Mr. Dozier also holds various stock options with exercise prices ranging from $61.26 to $109.13, and expiration dates between February 2, 2031, and February 3, 2035.
- Additionally, Mr. Dozier holds 11,669 Stock Units (LTIP) in a deferred phantom stock account, convertible to common stock on a one-for-one basis upon vesting.
Sentiment
Score: 6
Explanation: The filing reports a routine insider transaction (dividend reinvestment) which is generally neutral but can be seen as slightly positive due to an executive increasing their stake, albeit indirectly and through a standard plan.
Positives
- The acquisition of additional shares through dividend reinvestment indicates continued participation and confidence in the company by a key executive.
- Increased indirect beneficial ownership by an Executive Vice President aligns executive interests with those of shareholders.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing is a routine insider transaction report and does not provide information relevant to broader industry trends or competitive landscape analysis.
Stakeholder Impact
- Shareholders: A minor positive signal as an executive is increasing their indirect stake in the company, aligning interests.
Key Dates
| Date | Description |
|---|---|
| 01/01/2024 | Date exercisable for 20,682 stock options with an exercise price of $61.26. |
| 01/01/2025 | Date exercisable for 19,494 stock options with an exercise price of $62.8667. |
| 12/03/2025 | Transaction date for the acquisition of 61.354 common shares via dividend reinvestment. |
| 12/05/2025 | Signature date of the reporting person. |
| 01/01/2026 | Date exercisable for 38,900 stock options with an exercise price of $71.95. |
| 01/01/2027 | Date exercisable for 28,610 stock options with an exercise price of $104.16. |
| 01/01/2028 | Date exercisable for 25,460 stock options with an exercise price of $109.13. |
| 02/02/2031 | Expiration date for 20,682 stock options with an exercise price of $61.26. |
| 02/07/2032 | Expiration date for 19,494 stock options with an exercise price of $62.8667. |
| 02/08/2033 | Expiration date for 38,900 stock options with an exercise price of $71.95. |
| 02/05/2034 | Expiration date for 28,610 stock options with an exercise price of $104.16. |
| 02/03/2035 | Expiration date for 25,460 stock options with an exercise price of $109.13. |
Recommendation
holdThis Form 4 reports a routine dividend reinvestment by an executive, which is not typically a significant market-moving event. It indicates continued participation in the company's savings plan but does not provide new fundamental information to alter an investment thesis or warrant a change in recommendation.
Keywords
PACCAR, PCAR, Form 4, Insider Transaction, Beneficial Ownership, Dividend Reinvestment, Executive Compensation, Stock Options, Long Term Incentive Plan, SIP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.